Stent Architecture

• Cobalt chromium (L605) platform with 65µm strut thickness.
• Hybrid cell design comprising of an intelligent mix of open and
   close cells resulting in excellent radial strength with a high flexibility.
• 0.29% foreshortening
• Unique strut width variability that ensure a <3% recoil and 0.29%
   foreshortening
• Special electro-polishing technique eliminates surface nickel oxides


Low injury Design – Morphology Mediated ExpansionTM

• Conventional edge-flaring stent designs allow the stent to dog-bone
   during deployment.
• This dog-boning coupled with balloon overhang may cause edge injury.
• BioMime has struts with design variability which results in morphology
   mediated expansionTM, having a propensity to minimize stent edge
   injury.


Excellent Side Branch Access

• The area of the largest circle circumscribable in the cell of
   the stent expanded to the nominal diameter: Tc = 0.71
   mm2



Drug - Sirolimus

• Sirolimus acts on the common final pathway of cell division cycle without
   exceptional risk of necrosis induction
• Low drug loading of 1.25µgm/mm2 of Sirolimus
• Drug elution time of 30 days.


BioPolyTM

• BioPoly is Meril’s propriety biodegradable co-polymer
   formulation
• It offers uniformity in stent coating
• BioPoly Is highly stable during EtO process and there is no
   loss in polymer integrity
• It does-not web, crack, lump on stent or balloon surface
• Exceptionally low coating thickness of <2µm is possible



BioMime Coating integrity

• Meril’s validated coating technique ensures uniformity of coating on both
   abluminal and adluminal surfaces and around the stent edges

IT IS ONLY WHEN YOU HAVE A RESULT LIKE THESE!

SEM picture of BIOMIME endothelialisation

Complete and uniform endothelialisation, observed in porcine coronary artery model. At 28 or at 90 days, no significant differences were found in any histomorphometric parameters of lumen or neointimal hyperplasia (p > 0.05) between BIOMIME and Cypher in a pre-clinical porcine coronary artery model.

YOU WILL HAVE RESULTS LIKE THESE!


Currently not approved in U.S and Japan
Biomime is a registered trademark of Meril Life Science Pvt.Ltd.